Event Panel Schedule


Zoom #47 [Zoom]
Keynote: Cur­rent Cap­i­tals Mar­kets Overview
Webcast
496cd91d70ceb03473ae45fb1a656321_59e790a8391a2fcbcf8199032baa1379_120_120
Goldman Sachs & Co.
Ben Thorpe , Head of European Healthcare Investment Banking / Goldman Sachs & Co.
Ben is a Partner managing director in the Healthcare Investment Banking Team, which he joined in 1999. He has a degree form University of Durham.

Zoom #46 [Zoom]
What It Takes: A Suc­cess­ful U.S. IPO in A New Vir­tu­al World
Webcast
643216a2970110d7d23e6b0fbd166a9d_a27481856e6ae2a3f5195a6412356ab7_120_120
CureVac AG
Franz-Werner Haas , Acting Chief Executive Officer, Chief Operating Officer / CureVac AG
Franz-Werner Haas joined CureVac in June 2012. Before joining CureVac, he was Vice President Operations and Chief Compliance Officer of SYGNIS Pharma AG, where he was responsible for the execution of M&A and capital market transactions…

981084b3bc9b87289883a803810edb6c_e529d4f9840f3b804db9a2fefe2ddbe8_120_120
Goodwin Procter LLP
Robert Puopolo , Partner / Goodwin Procter LLP
Rob Puopolo, a partner in Goodwin’s Life Sciences practice, focuses his practice on representing public and privately held life sciences companies, as well as the venture capital firms, hedge funds and investment banks that focus on these companies.

0fa91081304d7a82916b6559284b3c41_e1ab4c1b954ba82d64c71553c5d7f428_120_120
SVB Leerink
Gabriel P. Cavazos , Managing Director / SVB Leerink
Gabriel Cavazos has been with Leerink Swann in the Healthcare Banking Division since 2008. Prior to that he worked in M&A at JP Morgan and previously at Merck and Pfizer. He has a BSc in Cellular & Molecular Biology from the University of…

Zoom #39
Al­ter­na­tives to IPOs: Re­v­erse Merg­ers, Di­rect List­ings, SPACs, Cross-Over Fi­nanc­ings, and De-Risk­ing Strate­gies
Webcast
5d93cdaebdb3139ed6c6175b14bab0d0_82a4228aded53074884281cae0055d58_120_120
Immatics NV
Harpreet Singh, PhD , CEO / Immatics Biotechnologies GmbH

7a94be6fea342c824e45c2eaeeeabdfa_c764612f772a730fa9704269b01022c4_120_120
Goodwin Procter LLP
Jocelyn Arel / Goodwin Procter LLP
Jocelyn Arel is a pioneer in the U.S. for her innovative work for clients on SPACs, with nearly two decades of successful SPACs transactions under her belt. Ms. Arel advises clients in all aspects of the SPAC lifecycle, including the formation and…

42c5704866e57ef43247e59bb960e2e9_19c5991a5018ab6589ca266de0b83728_120_120
Jefferies LLC
Gil Bar-Nahum , Managing Director / Jefferies LLC
Dr. Gil Bar-Nahum is a Managing Director in the Global Healthcare Investment Banking Group and leads the International Biotechnology effort at Jefferies. Dr. Bar-Nahum has over 17 years of experience and was an Executive Director in UBS Investment…

D2493046c84742878694054c691bb812_a8e6e23d36f0bf1d5be6370a2cd87b87_120_120
Solebury Trout
Chad Rubin , Managing Director / Solebury Trout
Chad has more than 18 years of experience in advising life science companies on topics including shareholder targeting, investor roadshows, capital markets transactions, messaging, and scenario analysis. His experience includes work in finance…

Zoom #46 [Zoom]
IPO Readi­ness: Suc­cess Fac­tors and Se­crets and Best Prac­tices for Eu­ro­pean For­eign Pri­vate Is­suers
Webcast
E0d781b039a088107db919449b7cf8e2_e238011ccf46e71b131021d90999ea48_120_120
Ernst & Young
Dr. Martin Steinbach , Partner, Head of IPO and Listing Services / Ernst & Young
A partner at one of the EY member firms in Germany, Martin is the EY EMEIA IPO Leader as well as the Head of IPO and Listing Services for EY GSA (Germany, Switzerland and Austria). He focuses on IPOs, investor relations, mergers and acquisitions, and…

3200c51d291d86bce0227d13913a1e45_37b4ca91dbf255b4a7d8036f8f6cee7c_120_120
Deutsche Bank AG
Joseph Oakenfold , Vice President / Deutsche Bank AG
Joe Oakenfold is the lead salesperson for Deutsche Banks‘ Depositary Receipts business in Europe bringing corporate issuers to the US capital markets and enabling access to the worlds’ largest pool of investment. With over 20 years’ experience, Joe…

593ba57538cd58097ce87761be09e194_de6090869b544cac3ed145cc04a4b5d3_120_120
Ernst & Young
Dirk Gallowsky , Partner / Ernst & Young

Bf2da8e0af1936ecb02d058ad2f814c7_d43be1645afb347585c8e4d2c7350ed8_120_120
NautaDutilh
Paul van der Bijl / NautaDutilh
Paul van der Bijl focuses on IPOs, follow-on offerings, public M&A, anti-takeover defenses, corporate governance and complex cross-border transactions. Notable transactions that Paul has been involved in include: the NASDAQ IPOs of InflaRx…

E0067a50d74f481bd7a0dc86c9ceddc6_cbce17007bd15701a06962646de76270_120_120
Solebury Trout
Brian Korb , Managing Director / Solebury Trout
Brian Korb is a Managing Director based in New York. Since joining the firm in 2000, Brian has worked with hundreds of companies in the life sciences space, crafting and executing investor relations and communication plans. He is a trusted advisor…
Export to Excel